β3-Adrenoceptors in the cardiovascular system: Putative roles in human pathologies
The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Differentiation of Receptor Systems activated by Sympathomimetic Amines
LANDS, A. M., ARNOLD, A., MCAULIFF, J. P., LUDUENA, F. P., & BROWN, T. G. (1967) · Nature · doi:10.1038/214597a0 · Cited by 2,065
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
Wang, Q., Curran, M. E., Splawski, I., Burn, T. C., Millholland, J. M., VanRaay, T. J., Shen, J., Timothy, K. W., Vincent, G. M., de Jager, T., et al. (1996) · Nature Genetics · doi:10.1038/ng0196-17 · Cited by 1,759
Flather, M. D., Shibata, M. C., Coats, A. J. S., Van Veldhuisen, D. J., Parkhomenko, A., Borbola, J., Cohen-Solal, A., Dumitrascu, D., Ferrari, R., Lechat, P., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi115 · Cited by 1,655
Bristow, M. R., Ginsburg, R., Umans, V, Fowler, M., Minobe, W., Rasmussen, R., Zera, P., Menlove, R., Shah, P., & Jamieson, S. (1986) · Circulation Research · doi:10.1161/01.res.59.3.297 · Cited by 1,327
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,124
Molecular Characterization of the Human β 3 -Adrenergic Receptor
Emorine, L. J., Marullo, S., Briend-Sutren, M.-M., Patey, G., Tate, K., Delavier-Klutchko, C., & Strosberg, A. D. (1989) · Science · doi:10.1126/science.2570461 · Cited by 1,088
A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart Failure
(2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442202 · Cited by 1,007
Enhanced Myocardial Function in Transgenic Mice Overexpressing the β 2 -Adrenergic Receptor
Milano, C. A., Allen, L. F., Rockman, H. A., Dolber, P. C., McMinn, T. R., Chien, K. R., Johnson, T. D., Bond, R. A., & Lefkowitz, R. J. (1994) · Science · doi:10.1126/science.8160017 · Cited by 740
Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs
Arch, J. R. S., Ainsworth, A. T., Cawthorne, M. A., Piercy, V., Sennitt, M. V., Thody, V. E., Wilson, C., & Wilson, S. (1984) · Nature · doi:10.1038/309163a0 · Cited by 728
Vascular Adrenoceptors: An Update
Guimarães, S., & Moura, D. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01495-9 · Cited by 700
Clément, K., Vaisse, C., Manning, B. S. J., Basdevant, A., Guy-Grand, B., Ruiz, J., Silver, K. D., Shuldiner, A. R., Froguel, P., & Strosberg, A. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508103330605 · Cited by 612
Walston, J., Silver, K., Bogardus, C., Knowler, W. C., Celi, F. S., Austin, S., Manning, B., Strosberg, A. D., Stern, M. P., Raben, N., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508103330603 · Cited by 589
Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium.
De Mey, J. G., & Vanhoutte, P. M. (1982) · Circulation Research · doi:10.1161/01.res.51.4.439 · Cited by 546
Widén, E., Lehto, M., Kanninen, T., Walston, J., Shuldiner, A. R., & Groop, L. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508103330604 · Cited by 541
Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes.
Méry, P. F., Lohmann, S. M., Walter, U., & Fischmeister, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1197 · Cited by 475
Méry, P. F., Pavoine, C., Belhassen, L., Pecker, F., & Fischmeister, R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74313-0 · Cited by 470
Functional beta3-adrenoceptor in the human heart.
Gauthier, C., Tavernier, G., Charpentier, F., Langin, D., & Le Marec, H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118823 · Cited by 461
Self-citationCampbell, D. L., Stamler, J. S., & Strauss, H. C. (1996) · The Journal of general physiology · doi:10.1085/jgp.108.4.277 · Cited by 441
Role of endothelium in dilator responses of spontaneously hypertensive rat arteries.
Konishi, M., & Su, C. (1983) · Hypertension · doi:10.1161/01.hyp.5.6.881 · Cited by 433
Hall, R. A., Ostedgaard, L. S., Premont, R. T., Blitzer, J. T., Rahman, N., Welsh, M. J., & Lefkowitz, R. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8496 · Cited by 404
Gauthier, C., Leblais, V, Kobzik, L., Trochu, J. N., Khandoudi, N., Bril, A., Balligand, J. L., & Le Marec, H. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2191 · Cited by 397
Self-citationTargeted Disruption of the β3-Adrenergic Receptor Gene
Susulic, V. S., Frederich, R. C., Lawitts, J., Tozzo, E., Kahn, B. B., Harper, M.-E., Himms-Hagen, J., Flier, J. S., & Lowell, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29483 · Cited by 393
8-bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes.
Shah, A. M., Spurgeon, H. A., Sollott, S. J., Talo, A., & Lakatta, E. G. (1994) · Circulation Research · doi:10.1161/01.res.74.5.970 · Cited by 377
β3 and Atypical β‐Adrenoceptors
Arch, J. R. S., & Kaumann, A. J. (1993) · Medicinal Research Reviews · doi:10.1002/med.2610130604 · Cited by 312
Cardiovascular and Metabolic Alterations in Mice Lacking Both β1- and β2-Adrenergic Receptors
Rohrer, D. K., Chruscinski, A., Schauble, E. H., Bernstein, D., & Kobilka, B. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16701 · Cited by 285
STRUCTURE AND FUNCTION OF THE β3-ADRENERGIC RECEPTOR
Strosberg, A. D. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.421 · Cited by 250
Recent Advances in Cardiac β2-Adrenergic Signal Transduction
Xiao, R.-P., Cheng, H., Zhou, Y.-Y., Kuschel, M., & Lakatta, E. G. (1999) · Circulation Research · doi:10.1161/01.res.85.11.1092 · Cited by 244
Liggett, S. B., Freedman, N. J., Schwinn, D. A., & Lefkowitz, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3665 · Cited by 234
Wahler, G. M., & Dollinger, S. J. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.268.1.c45 · Cited by 216
β3-Adrenoceptor agonists: potential, pitfalls and progress
Arch, J. R. S. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01421-8 · Cited by 213
Dessy, C., Saliez, J., Ghisdal, P., Daneau, G., Lobysheva, I. I., Frérart, F., Belge, C., Jnaoui, K., Noirhomme, P., Feron, O., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.532960 · Cited by 210
Torres, J., Darley-Usmar, V, & Wilson, M. T. (1995) · Biochemical Journal · doi:10.1042/bj3120169 · Cited by 206
Engelhardt, S., Hein, L., Keller, U., Klämbt, K., & Lohse, M. J. (2002) · Circulation Research · doi:10.1161/01.res.0000014966.97486.c0 · Cited by 206
Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species
Langin, D., Portillo, M. P., Saulnier-Blache, J.-S., & Lafontan, M. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90492-9 · Cited by 205
Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve.
Gross, W. L., Bak, M. I., Ingwall, J. S., Arstall, M. A., Smith, T. W., Balligand, J. L., & Kelly, R. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5604 · Cited by 200
β3-Adrenoceptors in the cardiovascular system
Gauthier, C., Langin, D., & Balligand, J.-L. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01562-5 · Cited by 187
Self-citationPeripheral adrenergic receptors in hypertension.
Michel, M. C., Brodde, O. E., & Insel, P. A. (1990) · Hypertension · doi:10.1161/01.hyp.16.2.107 · Cited by 187
Kupershmidt, S., Yang, T., Anderson, M. E., Wessels, A., Niswender, K. D., Magnuson, M. A., & Roden, D. M. (1999) · Circulation Research · doi:10.1161/01.res.84.2.146 · Cited by 183
Larsen, T. M., Toubro, S., van Baak, M. A., Gottesdiener, K. M., Larson, P., Saris, W. H., & Astrup, A. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.4.780 · Cited by 179
Modulation of human cardiac function through 4 β-adrenoceptor populations
Kaumann, A. J., & Molenaar, P. (1997) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00004999 · Cited by 179
Barbe, P., Millet, L., Galitzky, J., Lafontan, M., & Berlan, M. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15279.x · Cited by 175
Chung, H. S., Harris, A., Ciulla, T. A., & Kagemann, L. (1999) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(98)00037-8 · Cited by 172
The Effect of Diabetes on Expression of β1-,β2-, and β3-Adrenoreceptors in Rat Hearts
Dinçer, U. D., Bidasee, K. R., Güner, S., Tay, A., Özçelikay, A. T., & Altan, V. M. (2001) · Diabetes · doi:10.2337/diabetes.50.2.455 · Cited by 172
Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis
Schulz, R., Rassaf, T., Massion, P. B., Kelm, M., & Balligand, J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.005 · Cited by 171
Function and regulation of the β3-adrenoceptor
Strosberg, A. D., & Pietri-Rouxel, F. (1996) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)80011-3 · Cited by 167
Dessy, C., Moniotte, S., Ghisdal, P., Havaux, X., Noirhomme, P., & Balligand, J. L. (2004) · Circulation · doi:10.1161/01.cir.0000139331.85766.af · Cited by 166
Trochu, J., Leblais, V., Rautureau, Y., Bévérelli, F., Le Marec, H., Berdeaux, A., & Gauthier, C. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702797 · Cited by 166
Self-citationThe human β3-adrenoceptor: the search for a physiological function
Emorine, L., Blin, N., & Strosberg, A. D. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90118-x · Cited by 162
Moffett, S., Mouillac, B., Bonin, H., & Bouvier, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05663.x · Cited by 161
Kaumann, A. J., Bartel, S., Molenaar, P., Sanders, L., Burrell, K. M., Vetter, D., Hempel, P., Karczewski, P., & Krause, E. (1999) · Circulation · doi:10.1161/01.cir.99.1.65 · Cited by 160
Differences between the third cardiac β‐adrenoceptor and the colonic β3‐adrenoceptor in the rat
Kaumann, A. J., & Molenaar, P. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15648.x · Cited by 160
Bianchetti, A., & Manara, L. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb14100.x · Cited by 154
Upregulation of Functional β3-Adrenergic Receptor in the Failing Canine Myocardium
Cheng, H.-J., Zhang, Z.-S., Onishi, K., Ukai, T., Sane, D. C., & Cheng, C. (2001) · Circulation Research · doi:10.1161/hh1901.098042 · Cited by 151
β3-adrenoceptor deficiency blocks nitric oxide–dependent inhibition of myocardial contractility
Varghese, P. J., Harrison, R. W., Lofthouse, R. A., Georgakopoulos, D., Berkowitz, D. E., & Hare, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9323 · Cited by 144
Nitric oxide synthase expression and role during cardiomyogenesis
Bloch, W. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00160-1 · Cited by 137
Nodari, S., Metra, M., & Cas, L. D. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00054-0 · Cited by 129
Manara, L., Badone, D., Baroni, M., Boccardi, G., Cecchi, R., Croci, T., Giudice, A., Guzzi, U., Landi, M., & Fur, G. L. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15209.x · Cited by 128
Yasuda, S., & Lew, W. Y. W. (1997) · Circulation Research · doi:10.1161/01.res.81.6.1011 · Cited by 127
Chamberlain, P., Jennings, K., Paul, F., Cordell, J., Berry, A., Holmes, S., Park, J., Chambers, J., Sennitt, M. V., Stock, M. J., et al. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0801039 · Cited by 127
Blin, N., Camoin, L., Maigret, B., & Strosberg, A. D. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13306-3 · Cited by 125
Masuo, K., Katsuya, T., Fu, Y., Rakugi, H., Ogihara, T., & Tuck, M. L. (2005) · Circulation · doi:10.1161/circulationaha.104.519652 · Cited by 123
Genetics of human hypertension
Agarwal, A., Williams, G. H., & Fisher, N. D. L. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.02.009 · Cited by 122
The putative β4-adrenergic receptor is a novel state of the β1-adrenergic receptor
Granneman, J. G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e199 · Cited by 121
Liggett, S. B. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09002-9 · Cited by 115
Targeting endothelial dysfunction in hypertensive subjects
Thuillez, C., & Richard, V. J. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001889 · Cited by 113
Characterization of the human beta 3-adrenergic receptor gene.
Granneman, J. G., Lahners, K. N., & Chaudhry, A. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13147-7 · Cited by 113
A paired sibling analysis of the beta-3 adrenergic receptor and obesity in Mexican Americans.
Mitchell, B. D., Blangero, J., Comuzzie, A. G., Almasy, L. A., Shuldiner, A. R., Silver, K., Stern, M. P., MacCluer, J. W., & Hixson, J. E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci512 · Cited by 107
Vasodilating β-adrenoceptor blockers as cardiovascular therapeutics
Toda, N. (2003) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.09.001 · Cited by 103
Tavernier, G., Toumaniantz, G., Erfanian, M., Heymann, M., Laurent, K., Langin, D., & Gauthier, C. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00359-6 · Cited by 102
Self-citationDifferential interaction of β1- and β3-adrenergic receptors with Gi in rat adipocytes
Chaudhry, A., MacKenzie, R. G., Georgic, L. M., & Granneman, J. G. (1994) · Cellular Signalling · doi:10.1016/0898-6568(94)90093-0 · Cited by 101
The promoter and intron/exon structure of the human and mouse β3‐adrenergic‐receptor genes
van Spronsen, A., Nahmias, C., Krief, S., BRIEND‐SUTREN, M., Strosberg, A. D., & Emorine, L. J. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17861.x · Cited by 97
β3-Adrenergic Receptors Regulate Retinal Endothelial Cell Migration and Proliferation
Steinle, J. J., Booz, G. W., Meininger, C. J., Day, J. N. E., & Granger, H. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300368200 · Cited by 94
Rodent and human beta 3-adrenergic receptor genes contain an intron within the protein-coding block.
Granneman, J. G., Lahners, K. N., & Rao, D. D. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09278-8 · Cited by 93
Shen, Y. T., Cervoni, P., CLAUS, T., & Vatner, S. F. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20798-4 · Cited by 93
El‐Armouche, A., Zolk, O., Rau, T., & Eschenhagen, T. (2003) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.09.014 · Cited by 92
Endo, K., Yanagi, H., Hirano, C., Hamaguchi, H., Tsuchiya, S., & Tomura, S. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801177 · Cited by 91
Kohout, T. A., Takaoka, H., McDonald, P. H., Perry, S. J., Mao, L., Lefkowitz, R. J., & Rockman, H. A. (2001) · Circulation · doi:10.1161/hc4501.098933 · Cited by 90
Jockers, R., Silva, A. D., Strosberg, A. D., Bouvier, M., & Marullo, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9355 · Cited by 90
Morimoto, A., Hasegawa, H., Cheng, H.-J., Little, W. C., & Cheng, C. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01045.2003 · Cited by 88
Thomas, G. N., Tomlinson, B., Chan, J. C. N., Young, R., & Critchley, J. A. J. H. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801193 · Cited by 85
Moniotte, S., Vaerman, J. L., Kockx, M. M., Larrouy, D., Langin, D., Noirhomme, P., & Balligand, J. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1475 · Cited by 84
Briones, A. M., Daly, C. J., Jiménez‐Altayó, F., Martínez‐Revelles, S., González, J. M., McGrath, J. C., & Vila, E. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706369 · Cited by 83
Adrenergic mechanisms in blood vessels: Morphological and pharmacological aspects
Osswald, W., & Guimarães, S. (1983) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/bfb0031007 · Cited by 83
Chen, J., Radford, M. J., Wang, Y., Marciniak, T. A., & Krumholz, H. M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.7.947 · Cited by 81
Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines.
Dolan, J. A., Muenkel, H. A., Burns, M. G., Pellegrino, S. M., Fraser, C. M., Pietri, F., Strosberg, A. D., Largis, E. E., Dutia, M. D., & Bloom, J. D. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38827-0 · Cited by 81
Strazzullo, P., Iacone, R., Siani, A., Cappuccio, F. P., Russo, O., Barba, G., Barbato, A., D'Elia, L., Trevisan, M., & Farinaro, E. (2001) · Journal of Hypertension · doi:10.1097/00004872-200103000-00007 · Cited by 80
Enhanced Inhibition of L-type Ca2+ Current by β3-Adrenergic Stimulation in Failing Rat Heart
Zhang, Z.-S., Cheng, H.-J., Onishi, K., Ohte, N., Wannenburg, T., & Cheng, C. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089672 · Cited by 79
Cirino, G., Sorrentino, R., Bianca, R. D. D. V., Popolo, A., Palmieri, A., Imbimbo, C., Fusco, F., Longo, N., TAJANA, G., Ignarro, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931347100 · Cited by 79
Involvement of the β3 Adrenoceptor in Nebivolol-Induced Vasorelaxation in the Rat Aorta
de Groot, A. A., Mathy, M. J., van Zwieten, P. A., & Peters, S. L. M. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200308000-00012 · Cited by 75
Corella, D., Guillén, M., Portoles, O. D., Sorlí, J. V., Alonso, V., Folch, J., & Sáiz, C. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00894.x · Cited by 75
Oizumi, T., Daimon, M., Saitoh, T., Kameda, W., Yamaguchi, H., Ohnuma, H., Igarashi, M., Eguchi, H., Manaka, H., Tominaga, M., et al. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1579 · Cited by 74
CFTR chloride channels in human and simian heart
Warth, J. D., Collier, M. L., Hart, P., Geary, Y., Gelband, C. H., Chapman, T., Horowitz, B., & Hume, J. R. (1996) · Cardiovascular Research · doi:10.1016/s0008-6363(95)00245-6 · Cited by 73
Evans, B. A., Papaioannou, M., Hamilton, S., & Summers, R. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702688 · Cited by 68
Ponti, F. D., Gibelli, G., Croci, T., Arcidiaco, M., Crema, F., & Manara, L. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15294.x · Cited by 66
Effect of NO Donors on LV Diastolic Function in Patients With Severe Pressure-Overload Hypertrophy
Matter, C. M., Mandinov, L., Kaufmann, P. A., Vassalli, G., Jiang, Z., & Hess, O. M. (1999) · Circulation · doi:10.1161/01.cir.99.18.2396 · Cited by 65
Czuriga, I., Riecansky, Bodnár, Fulop, T., Kruzsicz, Kristof, & Édes, I. (2003) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1026180325278 · Cited by 62
Rozec, B. R., Quang, T. T., Noireaud, J., & Gauthier, C. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706648 · Cited by 61
Self-citationSennitt, M. V., Kaumann, A. J., Molenaar, P., Beeley, L. J., Young, P. W., Kelly, J., Chapman, H., Henson, S. M., Berge, J. M., Dean, D. K., et al. (1998) · PubMed · Cited by 59
Wilson, S., Chambers, J. K., Park, J. E., Ladurner, A. G., Cronk, D., Chapman, C. G., Kallender, H., Browne, M. J., Murphy, G. J., & Young, P. W. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20957-0 · Cited by 59
The Negative Inotropic Effect of β3-Adrenoceptor Stimulation in the Beating Guinea Pig Heart
Kitamura, T., Onishi, K., Dohi, K., 沖中, 務., Isaka, N., & Nakano, T. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200005000-00016 · Cited by 58
Vascular β-adrenoceptor function in hypertension and in ageing
Werstiuk, E. S., & Lee, R. M. K. W. (2000) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-78-6-433 · Cited by 57
Hutchinson, D. S., Bengtsson, T., Evans, B. A., & Summers, R. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704654 · Cited by 57
Atef, N., Lafontan, M., Double, A., Hélary, C., Ktorza, A., & Pénicaud, L. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00802-0 · Cited by 54
Dennedy, M. C., Houlihan, D. D., McMillan, H., & Morrison, J. J. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.125277 · Cited by 53
The cardiac β2-adrenergic signalling a new role for the cPLA2
Pavoine, C., & Defer, N. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.09.001 · Cited by 50
Joseph, S. S., Lynham, J. A., Molenaar, P., Grace, A. A., Colledge, W. H., & Kaumann, A. J. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0835-z · Cited by 47
Cardiac effects of the beta 3‐adrenoceptor agonist BRL35135 in man.
Wheeldon, N., McDevitt, D., & Lipworth, B. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04290.x · Cited by 45
Steinle, J. J., Zamora, D. O., Rosenbaum, J. T., & Granger, H. J. (2004) · Experimental Eye Research · doi:10.1016/j.exer.2004.08.015 · Cited by 45
Booth, J. V., Landolfo, K. P., Chesnut, L., Bennett‐Guerrero, E., Gerhardt, M. A., Atwell, D. M., El-Moalem, H. E., Stafford‐Smith, M., Funk, B. L., Kuhn, C. M., et al. (1998) · Anesthesiology · doi:10.1097/00000542-199809000-00008 · Cited by 44
Bosch, R., Schneck, A., Kiehn, J., Zhang, W., Hambrock, A., Eigenberger, B., Rüb, N., Gogel, J., Mewis, C., Seipel, L., et al. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00601-6 · Cited by 44
Pharmacological characteristics and species‐related variations of β3‐adrenergic receptors
Piétri‐Rouxel, F., & Strosberg, A. D. (1995) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1995.tb00288.x · Cited by 43
Rozec, B. R., Serpillon, S., Toumaniantz, G., Sèze, C., Rautureau, Y., Baron, O., Noireaud, J., & Gauthier, C. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.061 · Cited by 37
Self-citationRingel, J., Kreutz, R. H., Distler, A., & Sharma, A. M. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)00290-9 · Cited by 36
Control of β3-adrenergic receptor gene expression in brown adipocytes in culture
Klaus, S., Muzzin, P., Revelli, J. P., Cawthome, M. A., Giacobino, J., & Ricquier, D. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03502-x · Cited by 35
β3 Adrenergic Receptor Polymorphism and Obesity‐Related Phenotypes in Hypertensive Patients
Hao, K., Peng, S., Xing, H., Yu, Y., Huang, A., Hong, X., Wang, Y., Chen, C., Wang, B., Zhang, X., et al. (2004) · Obesity Research · doi:10.1038/oby.2004.17 · Cited by 35
Friedman, M., Wang, S. Y., Stahl, G. L., Johnson, R. G., & Sellke, F. W. (1995) · Journal of Applied Physiology · doi:10.1152/jappl.1995.79.6.1998 · Cited by 35
Age‐related macular degeneration: a leading cause of blindness
O'shea, J. G. (1996) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1996.tb138643.x · Cited by 35
Tonolo, G., Melis, M. G., Secchi, G., Atzeni, M. M., Angius, M. F., Carboni, A., Ciccarese, M., Malavasi, A., & Maioli, M. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917010-00006 · Cited by 34
Functional coupling of human beta 3-adrenoceptors to the KvLQT1/minK potassium channel
Kathöfer, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003331200 · Cited by 34
Potential Use of β3‐Adrenoceptor Antagonists in Heart Failure Therapy
Moniotte, S., & Balligand, J. (2002) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2002.tb00079.x · Cited by 33
Galitzky, J., Reverte, M., Portillo, M. P., Carpéné, C., Lafontan, M., & Berlan, M. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.3.e403 · Cited by 32
Iwase, M., Ichikawa, K., Tashiro, K., Iino, K., Shinohara, N., Ibayashi, S., Yoshinari, M., & Fujishima, M. (2000) · Hypertension Research · doi:10.1291/hypres.23.503 · Cited by 32
Rouget, C., Breuiller‐Fouché, M., Mercier, F. J., Leroy, M. J., Loustalot, C., Naline, E., Frydman, R., Croci, T., Morcillo, E. J., Advenier, C., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705616 · Cited by 31
Walston, J., Lowe, A., Silver, K. D., Yang, Y., Bodkin, N. L., HANSEN, B. C., & Shuldiner, A. R. (1997) · Gene · doi:10.1016/s0378-1119(96)00796-2 · Cited by 29
Vascular β‐adrenoceptor‐mediated responses in hypertension and ageing in rats
Borkowski, K. R., Gros, R., & Schneider, H. (1992) · Journal of Autonomic Pharmacology · doi:10.1111/j.1474-8673.1992.tb00387.x · Cited by 29
β 3-Adrenoceptors and the regulation of metabolism in adipose tissues
Arch, J. R. S., & Wilson, S. (1996) · Biochemical Society Transactions · doi:10.1042/bst0240412 · Cited by 26
Turner, N. C., & White, P. (1996) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199606000-00017 · Cited by 26
Rouget, C., Barthez, O., Goirand, F., Leroy, M., Breuiller-Fouché, M., Rakotoniaina, Z., Guérard, P., Morcillo, E. J., Advenier, C., Sagot, P., et al. (2005) · Biology of Reproduction · doi:10.1095/biolreprod.105.043695 · Cited by 26
Cardiovascular effects of beta 3‐adrenoceptor stimulation in perinephritic hypertension
Donckier, J. E., Massart, P., Mechelen, H. V., Heyndrickx, G. R., Gauthier, C., & Balligand, J. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00872.x · Cited by 25
Self-citationPorto, P. I., García, S. I., Dieuzeide, G., González, C. D., Landa, M. S., & Pirola, C. J. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000119367.21770.d7 · Cited by 24
Erhardt, É., Czakó, M., Csernus, K., Molnár, D., & Kosztolányi, G. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602164 · Cited by 24
Do most antihypertensive agents have a sympatholytic action?
de Champlain, J. (2001) · Current Hypertension Reports · doi:10.1007/s11906-001-0093-8 · Cited by 22
Pulkkinen, A., Kareinen, A., Saarinen, L., Heikkinen, S., Lehto, S., & Laakso, M. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90218-4 · Cited by 21
Manraj, M., Francke, S., Hébé, A., Ramjuttun, U. S., & Froguel, P. (2001) · Diabetologia · doi:10.1007/s001250051588 · Cited by 20
MELIS, M. G., Secchi, G., Brizzi, P., et al. (2002) · Clinical Science · doi:10.1042/cs1030397 · Cited by 14
Genomic cloning and species-specific properties of the recombinant canine β3-adrenoceptor
Lenzen, G., Piétri‐Rouxel, F., Drumare, M.-F., Amiard, A., Guillot, S., Archimbault, P., & Strosberg, A. D. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00809-7 · Cited by 14
Sheu, W. H., Lee, W., Yao, Y.-E., Jeng, C.-Y., Young, M. M.-S., & Chen, Y. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90066-5 · Cited by 14
The β3-adrenergic receptor Trp64Arg mutation is not associated with coronary artery disease
Stangl, K., Cascorbi, I., Laule, M., Stangl, V., Meisel, C., Wernecke, K., Ziemer, S., Baumann, G., Roots, I., & Hauner, H. (2001) · Metabolism · doi:10.1053/meta.2001.20179 · Cited by 14
Morrison, A. C., Brancati, F. L., Folsom, A. R., Smith, L., & Boerwinkle, E. (1999) · Human Genetics · doi:10.1007/s004399900096 · Cited by 11
The Trp64Arg polymorphism of the β3-adrenergic receptor is not increased in women with preeclampsia
Malina, A., Laivuori, H. M., Agatisa, P. K., Collura, L. A., Crombleholme, W. R., Sims, C. J., & Roberts, J. M. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2003.09.026 · Cited by 11
Zhang, C., Williams, M. A., Edwards, K. L., & Austin, M. A. (2005) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050400028576 · Cited by 6
Cited by
Borovac, J. A., D'Amario, D., Bozic, J., & Glavas, D. (2020) · World Journal of Cardiology · doi:10.4330/wjc.v12.i8.373 · Cited by 195
Nitric Oxide Synthases in Heart Failure
Carnicer, R., Crabtree, M. J., Sivakumaran, V., Casadei, B., & Kass, D. A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4824 · Cited by 163
Stohs, S. J., Preuss, H. G., & Shara, M. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.4446 · Cited by 115
Metadata
- Authors
- ROZEC, B., & GAUTHIER, C.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 111
- Issue
- 3
- Pages
- 652-673
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2087047630
- Cited by
- 181
- References
- 144
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.